Congenital long QT syndrome (LQTS) diagnosis is complicated by limited genetic testing at scale, low prevalence, and normal QT corrected interval in patients with high-risk genotypes. We developed a deep learning approach combining electrocardiogram…
Continue Reading
What You Should Know: – Phenomix Sciences, a precision medicine biotechnology company, released findings from a new survey revealing a growing demand for personalized obesity care. – The survey of 475 patients explored attitudes…
Continue Reading
Color Health, a genetic testing company, is using OpenAI’s newest, less expensive, large language model to equip doctors with pretreatment workup expertise that could speed up prior authorization requests for cancer screening diagnostics and…
Continue Reading
GeneDx, a genetic testing and analytics developer, announced this week that it is collaborating with Epic to expand access to its rapid whole genome sequencing services.WHY IT MATTERSThe focus is specifically on neonatal intensive…
Continue Reading
Synapticure, a telemedicine company focused on neurodegenerative disease, announced it is partnering with the ALS Association to offer Synapticure’s telehealth platform as a supplement to in-person care at ALS Certified Treatment Centers of Excellence…
Continue Reading
Karen Grinzaid, Assistant Professor of Human Genetics and Executive Director of JScreen, a national online genetic disease screening program based out of Emory University School of Medicine again joins eHealth Radio and the Health…
Continue Reading
Seattle Children’s Research Institute and tech giant Microsoft’s AI for Good Lab partnered on research examining the cause of sudden infant death syndrome (SIDS), and determined that genetic testing at birth may help to…
Continue Reading
The GEN-O application has proven its ability to revolution patient care and the genomic medicine landscape in the North West of England.Originally developed by Manchester University NHS Foundation Trust (MFT), GEN-O is reshaping virtual…
Continue Reading
What You Should Know:
– BillionToOne (BTO), a company dedicated to accessible and accurate genetic testing, has launched BabyPeek, a first-of-its-kind prenatal test uses advanced technology to predict a baby’s non-medical traits as early as…
Continue Reading
What You Should Know:
– Panacea, the genetic health services provider, announces nationwide commercial availability, enabling consumers to access potentially life-saving testing without doctor visits or insurance approval.
– Offering whole exome sequencing, Panacea conducts in-depth analysis of…
Continue Reading
